Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Titel:
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Auteur:
de Azambuja, E. Zardavas, D. Lemort, M. Rossari, J. Moulin, C. Buttice, A. D'Hondt, V. Lebrun, F. Lalami, Y. Cardoso, F. Sotiriou, C. Gil, T. Devriendt, D. Paesmans, M. Piccart-Gebhart, M. Awada, A.